Nerve Targeting via Myelin Protein Zero and the Impact of Dimerization on Binding Affinity.

fluorescence imaging fluorescence-guided surgery myelin protein zero nerve targeting

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
17 Dec 2022
Historique:
received: 03 11 2022
revised: 07 12 2022
accepted: 13 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Surgically induced nerve damage is a common but debilitating side effect. By developing tracers that specifically target the most abundant protein in peripheral myelin, namely myelin protein zero (P0), we intend to support fluorescence-guided nerve-sparing surgery. To that end, we aimed to develop a dimeric tracer that shows a superior affinity for P0. Following truncation of homotypic P0 protein-based peptide sequences and fluorescence labeling, the lead compound Cy5-P0 Dimerization resulted in a 1.5-fold increase in affinity compared to the mono-labeled counterpart (70.3 +/- 10.0 nM vs. 104.9 +/- 16.7 nM; Dimerization of the nerve-targeting peptide P0

Sections du résumé

BACKGROUND BACKGROUND
Surgically induced nerve damage is a common but debilitating side effect. By developing tracers that specifically target the most abundant protein in peripheral myelin, namely myelin protein zero (P0), we intend to support fluorescence-guided nerve-sparing surgery. To that end, we aimed to develop a dimeric tracer that shows a superior affinity for P0.
METHODS METHODS
Following truncation of homotypic P0 protein-based peptide sequences and fluorescence labeling, the lead compound Cy5-P0
RESULTS RESULTS
Dimerization resulted in a 1.5-fold increase in affinity compared to the mono-labeled counterpart (70.3 +/- 10.0 nM vs. 104.9 +/- 16.7 nM;
CONCLUSIONS CONCLUSIONS
Dimerization of the nerve-targeting peptide P0

Identifiants

pubmed: 36558148
pii: molecules27249015
doi: 10.3390/molecules27249015
pmc: PMC9786614
pii:
doi:

Substances chimiques

Myelin P0 Protein 0
cyanine dye 5 0
Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Resuscitation Council
ID : FWO S000922N
Organisme : NWO-TTW-VICI
ID : TTW BGT16141

Références

Chembiochem. 2018 Jun 4;:
pubmed: 29863301
Ther Deliv. 2012 Oct;3(10):1171-87
pubmed: 23116010
Chem Soc Rev. 2020 Oct 7;49(19):6848-6865
pubmed: 32870222
J Chin Med Assoc. 2003 Jan;66(1):13-8
pubmed: 12728969
Bioconjug Chem. 2010 Oct 20;21(10):1709-19
pubmed: 20812730
Theranostics. 2020 Aug 6;10(21):9890-9898
pubmed: 32863966
Curr Opin Chem Biol. 2006 Dec;10(6):537-43
pubmed: 17005436
Angew Chem Int Ed Engl. 2009;48(40):7346-9
pubmed: 19725090
Sci Transl Med. 2020 May 6;12(542):
pubmed: 32376766
Mol Imaging Biol. 2022 Jun 16;:
pubmed: 35711014
Mol Pharm. 2011 Dec 5;8(6):2444-53
pubmed: 22085282
J Nucl Med. 2020 Feb;61(2):234-241
pubmed: 31481575
Hand Clin. 2013 Aug;29(3):317-30
pubmed: 23895713
Mol Imaging Biol. 2012 Dec;14(6):708-17
pubmed: 22488576
Quant Imaging Med Surg. 2012 Sep;2(3):177-87
pubmed: 23256079
EJNMMI Res. 2021 May 29;11(1):50
pubmed: 34052912
World J Surg. 2008 Aug;32(8):1768-75
pubmed: 18521663
Med Hypotheses. 2014 Nov;83(5):588-92
pubmed: 25194501
Trends Mol Med. 2021 Apr;27(4):379-393
pubmed: 33436332
Neuroinformatics. 2011 Sep;9(2-3):159-66
pubmed: 21340747
Mol Imaging. 2011 Apr;10(2):91-101
pubmed: 21439254
Angew Chem Int Ed Engl. 2020 Jul 13;59(29):12154-12161
pubmed: 32324959
Bioorg Med Chem Lett. 2018 Feb 15;28(4):572-576
pubmed: 29402740
Chem Commun (Camb). 2020 May 14;56(39):5207-5222
pubmed: 32322844
Colorectal Dis. 2011 Dec;13(12):1326-34
pubmed: 20718836
Biochemistry. 2011 Apr 5;50(13):2691-700
pubmed: 21329363
Theranostics. 2014 Jun 07;4(8):823-33
pubmed: 24955143
Eur Urol. 2002 Aug;42(2):118-24
pubmed: 12160581
Prog Mol Biol Transl Sci. 2013;113:59-108
pubmed: 23244789
Bioconjug Chem. 2011 May 18;22(5):859-64
pubmed: 21480671
Ann Surg. 2019 Jul;270(1):69-76
pubmed: 30649014
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):30928-30933
pubmed: 33234563
Angew Chem Int Ed Engl. 2006 Apr 3;45(15):2348-68
pubmed: 16557636
World J Surg Oncol. 2006 Jan 31;4:6
pubmed: 16448559

Auteurs

Nataliia Berehova (N)

Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Tessa Buckle (T)

Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Maarten P van Meerbeek (MP)

Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Anton Bunschoten (A)

Laboratory of BioNanoTechnology, Wageningen University & Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.

Aldrik H Velders (AH)

Laboratory of BioNanoTechnology, Wageningen University & Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.

Fijs W B van Leeuwen (FWB)

Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Laboratory of BioNanoTechnology, Wageningen University & Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH